knowledge -WSS

knowledge

author：entertainment 2025-09-27 09:46:37 - browse：68943

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

hotspot

leisure time

WSS

Elevance PBM president out as customers face prescription chaos

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Anthony Fauci pushes back on GOP claims during Covid hearing

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Carbon Health diabetes program, a test of data

Wikipedia

knowledge

knowledge

Medical records are filled with copy

UnitedHealth CEO's Medicaid comments send insurer stocks diving

ChatGPT in medicine: STAT answers readers' burning questions

Fight over Supreme Court dialysis ruling puts kidney patients at risk

New air purifier tech could be key to improving indoor air quality

First transplant of an entire human eye performed

Walensky prepares to leave CDC — and Congress — behind

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Zepbound, Valneva's vaccine, and more

focus

What is STAT's opinion section for?

Type 2 diabetes prevention programs work at large scale: study

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Congress needs to close a vaccine

BD to buy Edwards patient monitoring unit for $4.2 billion

Medicare’s new pay boost for primary care is angering specialists

hotspot

leisure time

Wikipedia

explore